TNGX Latest Headlines

Guggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)

at www.tipranks.com (Mon, 1-Jun 8:01 AM)

Strong Cash Position and Pipeline Advances Define Tango Therapeutics’ Q1 2026 Update

Market Chameleon (Thu, 14-May 11:24 AM)

Tango Therapeutics Bolsters Cash Reserves Ahead of Key Trials: $343 Million Runway Extends Through 2028

Market Chameleon (Fri, 20-Mar 11:11 AM)

Tango Therapeutics Enters Promising Clinical Collaboration—Dual-Targeted Cancer Therapy Aims at MTAP-Deleted Tumors

Market Chameleon (Thu, 5-Mar 11:07 AM)